Extracorporeal shock wave therapy for Peyronie's disease: The patients' perspective

被引：0
|
作者：
Abdelbaky, A. [1 ]
Lawn, A. [1 ]
Nigam, R. [1 ]
机构：
[1] Royal Surrey Cty Hosp, Guildford, Surrey, England
来源：
JOURNAL OF SEXUAL MEDICINE | 2009年 / 6卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：455 / 455
页数：1
相关论文
共 50 条
  • [41] Long-term outcomes of extracorporeal shock wave therapy for acute Peyronie’s disease: a 10-year retrospective analysis
    Lorenzo Spirito
    Celeste Manfredi
    Roberto La Rocca
    Luigi Napolitano
    Mirko Preto
    Antonio Di Girolamo
    Davide Arcaniolo
    Marco De Sio
    Massimiliano Creta
    Nicola Longo
    International Journal of Impotence Research, 2024, 36 : 135 - 139
  • [42] Long-term outcomes of extracorporeal shock wave therapy for acute Peyronie's disease: a 10-year retrospective analysis
    Spirito, Lorenzo
    Manfredi, Celeste
    La Rocca, Roberto
    Napolitano, Luigi
    Preto, Mirko
    Di Girolamo, Antonio
    Arcaniolo, Davide
    De Sio, Marco
    Creta, Massimiliano
    Longo, Nicola
    INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2023, 36 (2) : 135 - 139
  • [43] Low-intensity laser diode plus extracorporeal shock wave therapy: a new treatment strategy in the management of Peyronie’s disease
    Lucio Dell’Atti
    Piero Ronchi
    World Journal of Urology, 2023, 41 : 2563 - 2568
  • [44] Extracorporeal shockwave therapy for Peyronie disease
    Groth, T
    Monga, M
    ARCHIVES OF ANDROLOGY, 2003, 49 (03): : 205 - 213
  • [45] Efficacy of extracorporeal shock wave therapy on plaque size and sexual function in patients with Peyronie's disease - Results of a prospective, randomized, placebo-controlled study
    Hatzichristodoulou, Georgios
    Meisner, Christoph
    Stenzl, Arnuff
    Lahme, Sven
    JOURNAL OF UROLOGY, 2007, 177 (04): : 251 - 251
  • [46] TADALAFIL ONCE DAILY AND EXTRACORPOREAL SHOCK WAVE THERAPY IN THE MANAGEMENT OF PATIENTS WITH PEYRONIE'S DISEASE AND ERECTILE DYSFUNCTION. RESULTS FROM A PROSPECTIVE RANDOMIZED TRIAL
    Palmieri, A.
    Imbimbo, C.
    Longo, N.
    Fusco, F.
    Verze, P.
    Creta, M.
    Arcaniolo, D.
    Grimaldi, G.
    Mirone, V
    EUROPEAN UROLOGY SUPPLEMENTS, 2011, 10 (02) : 317 - 317
  • [47] Extracorporeal shockwave therapy for Peyronie's disease: An alternative treatment?
    Poulakis, V
    Skriapas, K
    de Vries, R
    Dillenburg, W
    Ferakis, N
    Witzsch, U
    Melekos, M
    Becht, E
    ASIAN JOURNAL OF ANDROLOGY, 2006, 8 (03) : 361 - 366
  • [48] Extracorporeal Shockwave therapy for Peyronie's disease: Who benefits?
    Taylor, J
    Forster, JA
    Browning, AJ
    Biyani, CS
    JOURNAL OF ENDOUROLOGY, 2006, 20 (02) : 135 - 138
  • [49] Extracorporeal shock wave treatment for Peyronie's disease using EDAP LT-02; preliminary results
    Kiyota, H
    Ohishi, Y
    Asano, K
    Hasegawa, N
    Madarame, J
    Miki, K
    Kato, N
    Kimura, T
    Ishiyama, T
    Maeda, S
    Shimomura, T
    Shiono, Y
    Miki, J
    INTERNATIONAL JOURNAL OF UROLOGY, 2002, 9 (02) : 110 - 113
  • [50] Re: Extracorporeal Shock Wave Therapy (ESWT) in Urology: A Systematic Review of Outcome in Peyronie's Disease, Erectile Dysfunction, and Chronic Pelvic Pain
    Rassweiler, Jens
    EUROPEAN UROLOGY, 2018, 74 (01) : 115 - 117
12345